19 June 2013
Keywords: axis, genetics, opens, out, portfolio, uk, biopharmaceutical
Article | 18 September 1995
UK biopharmaceutical company Axis Genetics believes that clinical trials
may start as early as 1996 for its chimeric plant virus-based vaccines,
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 September 1995
18 June 2013
© 2013 thepharmaletter.com